Related Experiment Video
Updated: Aug 24, 2025

08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
2.5K
Welcome back Kotter-Developing a National Allergy strategy for Australia
Sandra L Vale1,2,3,4, Maria Said1,2,3,4, Jill Smith2
1National Allergy Strategy, Sydney NSW 2000, Australia.
The World Allergy Organization Journal
|October 21, 2022
Summary
A national allergy strategy was developed in Australia to address the growing prevalence of allergic diseases. This collaborative effort successfully secured funding for vital projects, improving allergy management nationwide.
Area of Science:
- Public Health
- Health Management
Background:
- Allergic diseases represent a significant and growing global health concern, particularly in Australia.
- In 2013, 20% of the Australian population reported having allergic diseases, highlighting a critical need for improved management strategies.
- The absence of a national strategy hindered the healthcare system's ability to cope with the increasing patient load.
Purpose of the Study:
- To develop and implement a national strategy for enhancing allergy management in Australia.
- To improve the quality of life for individuals with allergic diseases and their caregivers.
Main Methods:
- A partnership was formed between the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA).
- Kotter's Change Management Model guided the strategy's development and implementation.
- Stakeholder engagement was facilitated through development and implementation summits, supported by education grants.
- Advocacy efforts were undertaken to secure federal government funding.
Main Results:
- The National Allergy Strategy was successfully developed through the ASCIA and A&AA partnership.
- Two summits (development and implementation) and advocacy events led to securing five funding grants.
- These grants enabled the implementation of projects addressing urgent allergy-related issues across Australia.
Conclusions:
- The National Allergy Strategy, a joint initiative by ASCIA and A&AA, proved crucial for securing funding and implementing nationwide projects.
- The partnership fostered stakeholder engagement, essential for advocacy, guidance, and resource development.
- The strategy has successfully attracted funding for project implementation and resource creation, providing a framework for future advocacy and work.
Related Concept Videos
Allergic Reactions
28.1K
Overview
28.1K
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-IV: Nursing Management
3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
404
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
404
Allergic Drug Reactions
934
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
934
Cross-reactivity
31.4K
Overview
31.4K

